Blueshift Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Buy |
16,207
+8,566
| +112% | +$146K | 0.09% | 309 |
|
|
2025
Q1 | $488K | Buy |
+7,641
| New | +$488K | 0.19% | 157 |
|
|
2024
Q4 | – | Sell |
-2,096
| Closed | -$262K | – | 504 |
|
|
2024
Q3 | $262K | Buy |
+2,096
| New | +$262K | 0.06% | 297 |
|
|
2023
Q3 | – | Sell |
-5,912
| Closed | -$677K | – | 415 |
|
|
2023
Q2 | $677K | Buy |
+5,912
| New | +$677K | 0.26% | 99 |
|
|
2022
Q2 | – | Sell |
-6,101
| Closed | -$477K | – | 984 |
|
|
2022
Q1 | $477K | Buy |
6,101
+3,180
| +109% | +$249K | 0.04% | 462 |
|
|
2021
Q4 | $263K | Buy |
+2,921
| New | +$263K | 0.02% | 673 |
|
|
2021
Q3 | – | Sell |
-6,730
| Closed | -$523K | – | 1284 |
|
|
2021
Q2 | $523K | Buy |
+6,730
| New | +$523K | 0.03% | 550 |
|
|
2020
Q4 | – | Sell |
-3,025
| Closed | -$425K | – | 867 |
|
|
2020
Q3 | $425K | Buy |
+3,025
| New | +$425K | 0.06% | 380 |
|
|
2019
Q4 | – | Sell |
-3,101
| Closed | -$234K | – | 1025 |
|
|
2019
Q3 | $234K | Buy |
+3,101
| New | +$234K | 0.04% | 600 |
|